Clinical Trials on Mitochondrial Function in Finland

Total 90 results

University of Helsinki
Helsinki University Central Hospital; Institute for Molecular Medicine

Completed

NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients

Mitochondrial Myopathies

Finland
Turku University Hospital

Unknown

Cardiac Stroke Volume at Rest and During Different Exercise Intensities (SVproject)

Cardiac Function

Finland
Niilo Mäki Institute

Completed

Effectiveness of Play-Based Training on Executive Functioning in Pre-School Children

Problem Behavior | Executive Function

Finland
Finnish Institute for Health and Welfare
University of Oslo; Academy of Finland; The Finnish Funding Agency for Technology... and other collaborators

Completed

The Effect of Berry Consumption on Indicators of Cardiovascular Disease Risk

Inflammation | Blood Pressure | Platelet Function

Finland
Helsinki University Central Hospital
The University of Texas Health Science Center at San Antonio; City of Helsinki

Completed

Social Cognition and Interaction Training for Adults With Psychotic Disorders: An Open Pilot Study in Finland

Cognitive Function 1, Social | Psychotic Disorder

Finland
University of Helsinki
Technische Universität Dresden; University of Cambridge; University of Jyvaskyla

Unknown

MIndfulness for Students (Mindfulstud)

Stress | Well-being | Mindfulness | Functional Ability

Finland
Icahn School of Medicine at Mount Sinai
NeuroVision

Completed

Intraoperative Video Laryngoscopy as Adjunct for Nerve Monitoring (IOVL)

Vocal Cord Function in Neck Procedures

United States
Helsinki University Central Hospital

Recruiting

Behavioral Therapy in Patients With Rumination

Functional Gastrointestinal Disorders

Finland
Danisco

Terminated

Effect of Probiotic Supplement on Bowel Function (IBS2)

Irritable Bowel Syndrome

Finland
Finnish Institute of Occupational Health
City of Helsinki; Finnish Work Environment Fund; The Social Insurance Institution... and other collaborators

Completed

Comparing Interventions for Indoor Air -Related Functional Symptoms (TOSI)

Environmental Illness | Functional Symptoms

Finland
Verman Oy Ab

Unknown

Alpha-galactosidase Enzyme and Irritable Bowel Syndrome (ALFA)

Irritable Bowel Syndrome

Finland
Joint Authority for Päijät-Häme Social and Health...
Helsinki University Central Hospital; University of Helsinki

Completed

FMT in the Treatment of IBS (FMT-IBS)

Irritable Bowel Syndrome

Finland
Oy Karl Fazer Ab

Completed

Effects of Wheat Breads on Symptoms of IBS, a Pilot Study (Wheat-IBS)

Irritable Bowel Syndrome | Wheat Sensitivity

Finland
Oy Karl Fazer Ab

Completed

Effect of Two Different Rye Bread Types in Irritable Bowel Syndrome

Irritable Bowel Syndrome

Finland
Danisco

Completed

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms

Irritable Bowel Syndrome

Finland
Helsinki University Central Hospital
University of Helsinki

Unknown

Intra-graft Coagulation Events in Clinical Renal Transplantation and Delayed Graft Function (KTX)

End Stage Renal Disease | Kidney Transplantation | Reperfusion Injury | Delayed Graft Function

Finland
Helsinki University Central Hospital

Recruiting

Intravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal Function (INCARO)

Acute Abdomen | Radiocontrast Nephropathy

Finland
University of Helsinki

Active, not recruiting

Innovative Tools to Produce Legume-based Foods for Increased Consumer Acceptance (LeguComf)

IBS - Irritable Bowel Syndrome

Finland
VA Office of Research and Development
VHA Geriatrics and Extended Care; US Department of Health and Human Services... and other collaborators

Completed

Evaluation of Veteran-Directed Home and Community Based Services (VD-HCBS Eval)

Caregiving | Functional Impairment

United States
Helsinki University Central Hospital
University of Turku; Southern Health and Social Care Trust

Withdrawn

Voiding School as a Treatment of Children's Day-time Incontinence or Enuresis

Enuresis | Daytime Wetting | Functional Incontinence

Finland
Helsinki University Central Hospital

Recruiting

AIR-program and HUS Internet Therapy Compared to Treatment as Usual in Functional Disorders and Post Covid-19 Condition

Functional Disorders | Post Covid-19

Finland
Helsinki University Central Hospital
Turku University Hospital; University of Helsinki; Paijat-Hame Hospital District

Recruiting

Fecal Microbiota Transplantation for Irritable Bowel Syndrome Associated Food Intolerance (FinFMT-IBS)

Irritable Bowel Syndrome | Fecal Microbiota Transplantation

Finland
Memorial Hospital of Rhode Island
University of California, San Diego; National Heart, Lung, and Blood Institute... and other collaborators

Unknown

WHISH-2-Prevent Heart Failure

Heart Failure | Physical Activity | Elderly | Heart Failure With Reduced Ejection Fraction | Heart Failure With Normal Ejection Fraction | Women | Strength Training

United States
Rhode Island Hospital
United Therapeutics; University of Rhode Island

Recruiting

Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Ischemia Reperfusion Injury | Delayed Graft Function

United States
Helsinki University Central Hospital

Recruiting

Patient-reported Outcome Measures (PROMs) in Patients With Bodily Stress Syndrome: Protocol for a Prospective Cohort Study (SYMPA)

Fatigue | Irritable Bowel Syndrome | Fibromyalgia | Dysphagia | Chronic Fatigue Syndrome | Somatic Symptom | Exhaustion; Syndrome

Finland
Turku University Hospital

Recruiting

The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

IBS - Irritable Bowel Syndrome | Microbial Substitution

Finland
The University of Hong Kong
Chinese University of Hong Kong; Novartis Pharmaceuticals; Biofourmis Singapore...

Active, not recruiting

Daily Ambulatory Remote Monitoring System For Post-Dischage Management Of ADHF (DAVID-HF)

Heart Failure With Reduced Ejection Fraction

Hong Kong
Brown University
AstraZeneca

Recruiting

Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

Esophageal Cancer | Esophageal Adenocarcinoma | HER-2 Protein Overexpression | Gastroesophageal-junction Cancer

United States
Gulam Manji
Merck Sharp & Dohme LLC

Completed

Perioperative Chemo and Pembrolizumab in Gastric Cancer

Gastric Cancer | Adenocarcinoma of the Gastroesophageal Junction

United States
Rhode Island Hospital

Recruiting

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

Carpometacarpal Sprain | Thumb Sprain | Clostridium; Botulinum

United States
National Institute of Neurological Disorders and...

Completed

Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures

Movement Disorders

United States
National Cancer Institute (NCI)

Suspended

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Esophageal Adenocarcinoma | Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IVA Esophageal Adenocarcinoma... and other conditions

United States
AstraZeneca

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function (BalanceD-HF)

Heart Failure and Impaired Kidney Function

Spain, France, Germany, Italy, United States, Argentina, Czechia, Vietnam, Peru, China, Philippines, Austria, Canada, Japan, Malaysia, Poland, Taiwan, Thailand, Brazil, Finland, Greece, Israel, Mexico, United Kingdom, Turkey, Colombia, Slov... and more
Astellas Pharma Global Development, Inc.

Active, not recruiting

A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer (Spotlight)

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

United States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
AbbVie
Ironwood Pharmaceuticals, Inc.

Enrolling by invitation

Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C

Irritable Bowel Syndrome With Constipation | Functional Constipation

United States, Canada, Israel, Netherlands
Sucampo Pharma Americas, LLC
Takeda

Completed

Lubiprostone for Children With Constipation

Constipation - Functional

United States, United Kingdom, Netherlands, Poland, Belgium, France, Canada
Sucampo Pharma Americas, LLC
Sucampo AG

Completed

Lubiprostone in Children With Functional Constipation

Constipation - Functional

United States, United Kingdom, Canada, Netherlands, Poland, Belgium, France
AbbVie
Ironwood Pharmaceuticals, Inc.

Active, not recruiting

Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC) (LINZESS)

Irritable Bowel Syndrome With Constipation | Functional Constipation

United States, Belgium, Bulgaria, Canada, Estonia, Israel, Italy, Netherlands, Poland, Puerto Rico, Spain, Ukraine, United Kingdom, Germany
Novartis Pharmaceuticals

Completed

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients (TITRATION)

Heart Failure With Reduced Ejection Fraction

Hungary, Spain, Italy, United States, Germany, United Kingdom, Turkey, Slovakia, Bulgaria, Finland, Puerto Rico
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

Functional Constipation in Children Ages 6-17 Years

United States, Canada
Abbott Medical Devices

Completed

Hemodynamic-GUIDEd Management of Heart Failure (GUIDE-HF)

Heart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...

United States, Canada
Novartis Pharmaceuticals

Completed

randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure (OUTSTEP-HF)

Chronic Heart Failure With Reduced Ejection Fraction

Belgium, Estonia, Denmark, Greece, United Kingdom, Germany, Latvia, Lithuania, Spain, Netherlands, Bulgaria, Finland, Poland, Czechia, Iceland, Sweden, France, Ireland, Norway
Celgene

Completed

Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function (RENAL)

Multiple Myeloma | Non-Hodgkin's Lymphoma | AML | Solid Tumors | MDS | Hodgkin's Disease

United States
Novartis Pharmaceuticals

Completed

Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

Heart Failure With Preserved Ejection Fraction (HFpEF)

United States, Canada
AstraZeneca

Recruiting

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Gastric Cancer | Pancreatic Adenocarcinoma | Gastroesophageal Junction Cancer

United States, Spain, United Kingdom, Korea, Republic of, Japan, Taiwan, Malaysia, Canada, Singapore, Moldova, Republic of, Australia, Georgia
Novartis Pharmaceuticals

Completed

Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction (PARAGON-HF)

Heart Failure With Preserved Ejection Fraction

China, Germany, United States, Colombia, South Africa, Italy, Austria, Belgium, Croatia, Romania, Taiwan, Japan, Netherlands, Denmark, France, Israel, Spain, Switzerland, Korea, Republic of, Argentina, Canada, United Kingdom, Bulgaria, Gree... and more
Ardelyx

Recruiting

Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years

Irritable Bowel Syndrome With Constipation (IBS-C)

United States
Eli Lilly and Company
AstraZeneca

Completed

A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

Hepatocellular Carcinoma | Gastric Cancer | Non-Small Cell Lung Cancer | Gastroesophageal Junction Adenocarcinoma

United States, Spain, Korea, Republic of, Taiwan, Germany, Italy, France, Israel
Ardelyx

Completed

A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C (T3MPO-1)

Constipation Predominant Irritable Bowel Syndrome

United States
Alexion Pharmaceuticals

Terminated

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Myasthenia Gravis

United States, Canada, United Kingdom

Clinical Trials on Mitochondrial Function in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations